Varex Imaging Corp (VREX)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Varex Imaging Corp.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 3 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 11.20 $ — 57% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
3 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -0.6% failed
- More than 10% revenue growth is expected for the coming year 3.9% failed
- Share count grows by less than 3% a year -0.2% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 6.4% failed
- Gross margin at 40% or higher and without meaningful erosion 34.4% failed
- Goodwill from acquisitions does not grow faster than revenue 17.9% passed
- Net debt below twice EBITDA 70.5 x EBITDA failed
- Operating cash flow covers the profits of the last three years 268 m passed
- Return on capital at 15% or higher, or up versus two years ago -3.0% failed
- Insiders hold at least 10% or are net buyers 1.7% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 60.7% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 5
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 09/30/2026 | 0.78 | 0.26 – 0.95 | 871 | -13.6% | 5 |
| 09/30/2027 | 1.06 | 0.92 – 1.26 | 905 | 36.8% | 5 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.22 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.01 | – | 200 | 5.20 | -0.20 | 10 | 5 |
| 2025: Q1 | 0.13 | 296.60 | 213 | 3.20 | 3.20 | 17 | 10 |
| 2025: Q2 | -2.15 | -6,418.30 | 203 | -2.90 | -43.90 | 8 | 1 |
| 2025: Q3 | 0.29 | – | 229 | 11.30 | 5.30 | 8 | 2 |
| 2025: Q4 | 0.05 | – | 210 | 4.90 | 1.10 | -16 | -27 |
| 2026: Q1 | -0.19 | -243.40 | 216 | 1.50 | -3.80 | -2 | -8 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 620 | 109 | 69 | 1.78 | 74 | 526 | 622 |
| 2017 | 698 | 84 | 52 | 1.36 | 75 | 379 | 1,040 |
| 2018 | 773 | 45 | 28 | 0.72 | 85 | 426 | 989 |
| 2019 | 781 | 8 | 16 | 0.40 | 72 | 446 | 1,041 |
| 2020 | 738 | -34 | -58 | -1.49 | 13 | 452 | 1,140 |
| 2021 | 818 | 74 | 17 | 0.43 | 93 | 483 | 1,148 |
| 2022 | 859 | 88 | 30 | 0.73 | 17 | 533 | 1,184 |
| 2023 | 893 | 77 | 47 | 0.94 | 108 | 568 | 1,250 |
| 2024 | 811 | 32 | -48 | -1.17 | 47 | 535 | 1,217 |
| 2025 | 845 | -28 | -70 | -1.70 | 42 | 473 | 1,107 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial.
| Employees | 2,450 |
|---|---|
| Headquarters | Salt Lake City, UT |
| Address | 1678 S. Pioneer Road, 84104 Salt Lake City, United States |
| Phone | 801 972 5000 |
| Website | vareximaging.com |
| IPO Date | 20. Jan 2017 |
| ISIN | US92214X1063 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Sunny S. Sanyal | President, CEO & Director | 1964 |
| Shubham Maheshwari | CFO & Principal Accounting Officer | 1971 |
| Kimberley E. Honeysett J.D. | Advisor | 1970 |
| Mark S. Jonaitis | Senior VP & GM of X-Ray Sources | 1962 |
| Andrew J. Hartmann | Senior VP & GM of X-Ray Detectors | 1963 |
| Christopher John Belfiore | Director of Investor Relations | – |
| Matthew Martinez | Chief Legal Officer & Corporate Secretary | 1982 |
| Wouter Vlaanderen | Vice President of Global Marketing | – |
| Karen Aranki | Chief Human Resources Officer | 1975 |
| Victor Garcia | Senior Vice President of Regulatory & Quality Compliance | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.